Andres E. Dulcey
1Patents
0h-index
9Co-inventors
19Inventor score
Filing activity: Mar 8, 2019 → Mar 8, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11649218B2 | C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.